267 related articles for article (PubMed ID: 29786006)
1. Rebound inflammation after an intravitreal injection in Vogt-Koyanagi-Harada syndrome.
Ranjan R; Agarwal M
Indian J Ophthalmol; 2018 Jun; 66(6):863-865. PubMed ID: 29786006
[TBL] [Abstract][Full Text] [Related]
2. Choroidal Detachment following an Intravitreal Injection in a Patient with Vogt-Koyanagi- Harada Disease.
Kumar N; Rana N; Bansal R
Ocul Immunol Inflamm; 2021 Feb; 29(2):396-398. PubMed ID: 31664881
[No Abstract] [Full Text] [Related]
3. [Vogt-Koyanagi-Harada syndrome in children - a case report].
Bušányová B; Tomčíková D; Gerinec A
Cesk Slov Oftalmol; 2013 Jun; 69(2):81-6. PubMed ID: 23964873
[TBL] [Abstract][Full Text] [Related]
4. Management of recurrent inflammatory choroidal neovascular membrane secondary to Vogt-Koyanagi-Harada syndrome, using combined intravitreal injection of bevacizumab and triamcinolone acetate.
Pai SA; Hebri SP; Lootah AM
Indian J Ophthalmol; 2012; 60(6):551-2. PubMed ID: 23202396
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal bevacizumab injection for persistent serous retinal detachment associated with Vogt-Koyanagi-Harada disease.
Park HS; Nam KY; Kim JY
Graefes Arch Clin Exp Ophthalmol; 2011 Jan; 249(1):133-6. PubMed ID: 20689964
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal bevacizumab injection in a 14-year-old Vogt-Koyanagi-Harada patient with choroidal neovascular membrane.
Raffa L; Bawazeer A
Can J Ophthalmol; 2009 Oct; 44(5):615-6. PubMed ID: 19789612
[No Abstract] [Full Text] [Related]
7. Intravitreal bevacizumab for iatrogenic choroidal neovascular membrane following vitreoretinal surgery for retinal detachment.
Appanraj R; Duraiswamy H; Saravanan V; Manayath G; Venkatapathy N
Indian J Ophthalmol; 2020 Jun; 68(6):1201-1203. PubMed ID: 32461482
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal bevacizumab for choroidal neovascularization secondary to Vogt-Koyanagi-Harada syndrome.
Wu L; Evans T; Saravia M; Schlaen A; Couto C
Jpn J Ophthalmol; 2009 Jan; 53(1):57-60. PubMed ID: 19184312
[TBL] [Abstract][Full Text] [Related]
9. Bilateral peripapillary choroidal neovascular membranes in Vogt-Koyanagi-Harada disease.
Banerjee M; Kumar A; Azad SV; Chawla R
BMJ Case Rep; 2024 Jun; 17(6):. PubMed ID: 38937264
[TBL] [Abstract][Full Text] [Related]
10. EXUDATIVE RETINAL DETACHMENT CAUSED BY A CHOROIDAL NEOVASCULAR MEMBRANE IN HALLERMANN-STREIFF SYNDROME.
AlAli A; Bourgault S; Clark I; Lam WC
Retin Cases Brief Rep; 2018 Winter; 12(1):45-47. PubMed ID: 27648586
[TBL] [Abstract][Full Text] [Related]
11. Treatment of persistent serous retinal detachment in Vogt-Koyanagi-Harada syndrome with intravitreal bevacizumab during the systemic steroid treatment.
Reibaldi M; Russo A; Avitabile T; Uva MG; Franco L; Longo A; Toro MD; Cennamo G; Mariotti C; Neri P; Noci ND; Russo V
Retina; 2014 Mar; 34(3):490-6. PubMed ID: 23903795
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal triamcinolone acetonide in Vogt-Koyanagi-Harada syndrome.
Karacorlu M; Arf Karacorlu S; Ozdemir H
Eur J Ophthalmol; 2006; 16(3):481-3. PubMed ID: 16761256
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of Intravitreal Bevacizumab in Choroidal Neovascularization in Vogt-Koyanagi-Harada Disease- A Prospective Study.
Sakata VM; Morita C; Lavezzo MM; Rodriguez EEC; Abdallah SF; Pimentel SLG; Hirata CE; Yamamoto JH
Ocul Immunol Inflamm; 2021 Apr; 29(3):572-578. PubMed ID: 31746659
[No Abstract] [Full Text] [Related]
14. INFLAMMATORY CHOROIDAL NEOVASCULAR MEMBRANE: Long-Term Visual and Anatomical Outcomes After Intravitreal Anti-vascular Endothelial Growth Factor Therapy.
Dʼsouza P; Ranjan R; Babu U; Kanakath AV; Saravanan VR
Retina; 2018 Jul; 38(7):1307-1315. PubMed ID: 28520642
[TBL] [Abstract][Full Text] [Related]
15. Peripheral choroidal neovascular membrane in a case of peripheral exudative hemorrhagic chorioretinopathy managed with combination therapy.
Takkar B; Roy S; Sodhi PK; Azad S; Bajwa GS
Int Ophthalmol; 2017 Apr; 37(2):429-431. PubMed ID: 27312539
[TBL] [Abstract][Full Text] [Related]
16. Topical difluprednate for treatment of serous retinal detachment and panuveitis associated with Vogt-Koyanagi-Harada disease.
Lu S; Taban M
Digit J Ophthalmol; 2016; 22(2):54-7. PubMed ID: 27582676
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal triamcinolone in the treatment of serous retinal detachment in Vogt-Koyanagi-Harada syndrome.
Andrade RE; Muccioli C; Farah ME; Nussenblatt RB; Belfort R
Am J Ophthalmol; 2004 Mar; 137(3):572-4. PubMed ID: 15013890
[TBL] [Abstract][Full Text] [Related]
18. Retrolental Bullous Retinal Detachment as the Presenting Feature of Vogt-Koyanagi-Harada Disease in an Elderly Indian Female: Diagnostic and Therapeutic Challenge.
Kumar Menia N; Bansal R; Gupta V
Ocul Immunol Inflamm; 2024 May; 32(4):429-432. PubMed ID: 36897931
[TBL] [Abstract][Full Text] [Related]
19. The effect on choroidal changes of the route of systemic corticosteroids in acute Vogt-Koyanagi-Harada disease.
Park UC; Cho IH; Lee EK; Yu HG
Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1203-1211. PubMed ID: 28382438
[TBL] [Abstract][Full Text] [Related]
20. Retinal Pigment Epithelium Detachment in Acute Vogt-Koyanagi-Harada Disease: An Unusual Finding at Presentation.
Khochtali S; Ksiaa I; Megzari K; Khairallah M
Ocul Immunol Inflamm; 2019; 27(4):591-594. PubMed ID: 29513616
[No Abstract] [Full Text] [Related]
[Next] [New Search]
